Hydrocodone compound and Hydramine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hydrocodone compound (homatropine methylbromide; hydrocodone bitartrate) and Hydramine (diphenhydramine hydrochloride). Common drug interactions include nasopharyngitis among females and erythema multiforme among males.

The phase IV clinical study analyzes what interactions people have when they take Hydrocodone compound and Hydramine. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Hydrocodone compound?

Hydrocodone compound has active ingredients of homatropine methylbromide; hydrocodone bitartrate. It is often used in pain. eHealthMe is studying from 518 Hydrocodone compound users. Check the latest studies of Hydrocodone compound.

What is Hydramine?

Hydramine has active ingredients of diphenhydramine hydrochloride. It is often used in insomnia. eHealthMe is studying from 114,900 Hydramine users. Check the latest studies of Hydramine.



On Jul, 14, 2026

21 people who take Hydrocodone compound and Hydramine together, and have interactions are studied.

Hydrocodone compound and Hydramine drug interactions.

What are the common drug interactions of Hydrocodone Compound and Hydramine, by gender? *:

female:

  1. Nasopharyngitis (inflammation of the nasopharynx)
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Infusion site erythema (reddening of the skin at infusion site)
  4. Infusion site swelling
  5. Bladder cancer
  6. Dyspnoea (difficult or laboured respiration)
  7. Infusion site rash
  8. Abdominal tenderness
  9. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  10. Dehydration (dryness resulting from the removal of water)

male:

  1. Erythema multiforme (a type of hypersensitivity reaction)
  2. Pneumonia
  3. Pulmonary embolism (blockage of the main artery of the lung)
  4. Pyrexia (fever)
  5. Dyspnoea (difficult or laboured respiration)

What are the common drug interactions of Hydrocodone Compound and Hydramine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Erythema multiforme (a type of hypersensitivity reaction)
  2. Pneumonia
  3. Pulmonary embolism (blockage of the main artery of the lung)
  4. Pyrexia (fever)

50-59:

  1. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  2. Dehydration (dryness resulting from the removal of water)
  3. Frequent bowel movements
  4. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  5. Headache (pain in head)
  6. Leukopenia (less number of white blood cells in blood)
  7. Nasal disorder (diseases of nose)
  8. Neutropenia (an abnormally low number of neutrophils)
  9. Pulmonary embolism (blockage of the main artery of the lung)
  10. Thrombocytopenia (decrease of platelets in blood)

60+:

  1. Asthenia (weakness)
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Colon cancer
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Neuropathy peripheral (surface nerve damage)
  6. Weight decreased
  7. Dyspnoea (difficult or laboured respiration)
  8. Bladder cancer
  9. Sinusitis (inflammation of sinus)

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 11 people, 52.38%
  2. Lung Cancer - Non-Small Cell (lung cancer): 5 people, 23.81%
  3. Joint Pain: 5 people, 23.81%
  4. Cough: 5 people, 23.81%
  5. Bone Marrow Conditioning Regimen: 3 people, 14.29%
  6. Viraemia (presence of a virus in the blood stream): 2 people, 9.52%
  7. B-Cell Unclassifiable Lymphoma High Grade (rapidly progressing unclassifiable b-cell cancer difficult to treat- high grade): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Hydrocodone compound and Hydramine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Hydrocodone compound and Hydramine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Hydrocodone compound:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Hydramine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydrocodone compound and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydramine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on homatropine methylbromide; hydrocodone bitartrate and diphenhydramine hydrochloride (the active ingredients of Hydrocodone compound and Hydramine, respectively), and Hydrocodone compound and Hydramine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: